Influenza, SARS-CoV-2 y aspergilosis pulmonar invasiva
Authors:
- 1 January 2021
- journal article
- editorial
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 57, 11-12
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It SporesClinical Infectious Diseases, 2020
- COVID-19–associated Pulmonary AspergillosisAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19The Lancet Respiratory Medicine, 2020
- Aspergilosis invasora como complicación de infección por virus influenza H3N2Archivos de Bronconeumología, 2020
- COVID‐19 associated pulmonary aspergillosisMycoses, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter studyMedical Mycology, 2019
- Influenza-associated Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- Fatal Aspergillosis in a Patient with SARS Who Was Treated with CorticosteroidsNew England Journal of Medicine, 2003